PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.16%
Net income growth under 50% of AVGO's 32.35%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.08%
Negative yoy D&A while AVGO is 0.66%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-29.17%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
9.23%
SBC growth well above AVGO's 0.40%. Michael Burry would flag major dilution risk vs. competitor’s approach.
66.08%
Less working capital growth vs. AVGO's 155.46%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
103.68%
AR growth well above AVGO's 90.99%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
27.39%
Inventory shrinking or stable vs. AVGO's 86.55%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-139.08%
Both negative yoy AP, with AVGO at -129.03%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
132.91%
Lower 'other working capital' growth vs. AVGO's 377.48%. David Dodd would see fewer unexpected short-term demands on cash.
-73.47%
Both negative yoy, with AVGO at -1059.38%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
57.42%
Operating cash flow growth above 1.5x AVGO's 18.30%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-34.21%
Negative yoy CapEx while AVGO is 8.63%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-6.12%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
3.68%
Liquidation growth of 3.68% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-300.00%
Both yoy lines negative, with AVGO at -300.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-14.07%
We reduce yoy invests while AVGO stands at 253.49%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
49.21%
We repay more while AVGO is negative at -66400.00%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
-624.14%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.